The Non-LCH Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in rare histiocytoses.
Current members of the Non-LCH Steering Committee Include:
Gaurav Goyal - Chair
University of Alabama at Birmingham - Birmingham, AL USA
Term of Office: 2024 - 2028
Jithma Abeykoon
Mayo Clinic - Rochester, MN USA
Term of Office: 2026 - 2030
Eli Diamond
Memorial Sloan Kettering Cancer Center - New York, NY, USA
Term of Office: 2023 - 2027
Benjamin Durham
Memorial Sloan Kettering Cancer Center - New York, NY USA
Term of Office: 2025 - 2029
Jean-Francoise Emile
Versailles University, Paris-Saclay University - Boulogne, France
Term of Office: 2025 - 2029
Julien Haroche
Hopital Pitie-Salpetriere - Paris, France
Term of Office: 2022 - 2026
Zdenka Krenova
University Children Hospital, Brno, ICRC Brno - Brno, Czech Republic
Term of Office: 2023 - 2027
Francesco Pegoraro
Meyer Children's Hospital IRCCS - Florence, Italy
Term of Office: 2026 - 2029
Jennifer Picarsic
Cincinnati Children’s Hospital Medical Center - Cincinnati, OH, USA
Term of Office: 2023 - 2027
Aishwarya Ravindran
University of Alabama at Birmingham - Birmingham, AL USA
Term of Office: 2026 - 2030
Jerome Razanamahery
Dijon University Hospital - Dijon, France
Term of Office: 2026 - 2030
Karen Rech
Mayo Clinic - Rochester, MN, USA
Term of Office: 2023 - 2027
Aki Sato
University of Tokyo - Tokyo, Japan
Term of Office: 2026 - 2030